131 related articles for article (PubMed ID: 6260864)
21. Morphologic changes produced by amdinocillin alone and in combination with beta-lactam antibiotics: in vitro and in vivo.
Kramer MJ; Mauriz YR; Timmes MD; Robertson TL; Cleeland R
Am J Med; 1983 Aug; 75(2A):30-41. PubMed ID: 6311003
[TBL] [Abstract][Full Text] [Related]
22. Mecillinam resistance in Escherichia coli is conferred by loss of a second activity of the AroK protein.
Vinella D; Gagny B; Joseleau-Petit D; D'Ari R; Cashel M
J Bacteriol; 1996 Jul; 178(13):3818-28. PubMed ID: 8682786
[TBL] [Abstract][Full Text] [Related]
23. Activity of mecillinam against Escherichia coli resistant to third-generation cephalosporins.
Wootton M; Walsh TR; Macfarlane L; Howe RA
J Antimicrob Chemother; 2010 Jan; 65(1):79-81. PubMed ID: 19915068
[TBL] [Abstract][Full Text] [Related]
24. [Effects of ampicillin and cefazolin combined with mecillinam (author's transl)].
Stille W; Bischof-Léger E; Helm EB
Arzneimittelforschung; 1978; 28(10):1661-4. PubMed ID: 226099
[TBL] [Abstract][Full Text] [Related]
25. Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Lampri N; Galani I; Poulakou G; Katsarolis I; Petrikkos G; Giamarellou H; Souli M
J Antimicrob Chemother; 2012 Oct; 67(10):2424-8. PubMed ID: 22665388
[TBL] [Abstract][Full Text] [Related]
26. Mecillinam in urinary tract infections and in septicaemia.
Frimodt-Møller N; Ravn TJ
Infection; 1979; 7(1):35-7. PubMed ID: 217836
[TBL] [Abstract][Full Text] [Related]
27. Synergistic and bactericidal activities of mecillinam, amoxicillin and clavulanic acid combinations against extended-spectrum β-lactamase (ESBL)-producing Escherichia coli in 24-h time-kill experiments.
Skarp KP; Shams A; Montelin H; Lagerbäck P; Tängdén T
Int J Antimicrob Agents; 2019 Jan; 53(1):74-79. PubMed ID: 30236958
[TBL] [Abstract][Full Text] [Related]
28. [Combined effect of 6/N,N-1',6'-hexyleneformamidine-penicillanic acid (preparation HX) and selected beta-lactam antibiotics on E. coli and Salmonella. I. Studies in vitro].
Zaremba M; Zukowska-Nytko K; Borowski J
Med Dosw Mikrobiol; 1982; 34(1-2):27-36. PubMed ID: 6292594
[No Abstract] [Full Text] [Related]
29. Comparison of in vitro and in vivo ampicillin susceptibility of Escherichia coli pretreated with low concentrations of mecillinam and ampicillin.
van der Voet GB; Mattie H; van Furth R
Scand J Infect Dis; 1983; 15(1):97-101. PubMed ID: 6302833
[TBL] [Abstract][Full Text] [Related]
30. In vitro susceptibility to mecillinam of Escherichia coli strains isolated from the urine of pregnant women.
Duployez C; Loiez C; Cattoen C; Descamps D; Wallet F; Vachée A;
Med Mal Infect; 2016 Dec; 46(8):436-441. PubMed ID: 27609597
[TBL] [Abstract][Full Text] [Related]
31. Effect of beta-lactamase and salt on mecillinam susceptibility of enterobacterial strains.
Bongaerts GP; Bruggeman-Ogle KM
Antimicrob Agents Chemother; 1980 Nov; 18(5):680-6. PubMed ID: 6255865
[TBL] [Abstract][Full Text] [Related]
32. Susceptibility to mecillinam and other antibiotics of 28 O-serotypes of Yersinia enterocolitica.
Juhlin I; Winblad S
J Antimicrob Chemother; 1981 Oct; 8(4):291-7. PubMed ID: 6271722
[No Abstract] [Full Text] [Related]
33. Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases.
Sougakoff W; Jarlier V
J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():9-14; discussion 63-5. PubMed ID: 11051618
[TBL] [Abstract][Full Text] [Related]
34. Preliminary physiologic characterization and genetic analysis of a new Escherichia coli mutant, lov, resistant to mecillinam.
Bouloc P; Jaffé A; D'Ari R
Rev Infect Dis; 1988; 10(4):905-10. PubMed ID: 2847279
[TBL] [Abstract][Full Text] [Related]
35. Growth properties of mecillinam-resistant bacterial variants in urine.
Anderson JD; Adams MA; Webster HM; Smith L
Antimicrob Agents Chemother; 1977 Nov; 12(5):559-62. PubMed ID: 200171
[TBL] [Abstract][Full Text] [Related]
36. Escherichia coli resistance to beta-lactam antibiotics through a decrease in the affinity of a target for lethality.
Spratt BG
Nature; 1978 Aug; 274(5672):713-5. PubMed ID: 209344
[No Abstract] [Full Text] [Related]
37. Buoyant density studies of several mecillinam-resistant and division mutants of Escherichia coli.
Bylund JE; Haines MA; Walsh K; Bouloc P; D'Ari R; Higgins ML
J Bacteriol; 1991 Sep; 173(17):5396-402. PubMed ID: 1885519
[TBL] [Abstract][Full Text] [Related]
38. Mecillinam susceptibility in Victorian third generation cephalosporin-nonsusceptible Escherichia coli urinary isolates.
Olenski M; Jardine D; Poy Lorenzo YS; Crowe A
Pathology; 2021 Oct; 53(6):803-805. PubMed ID: 33526242
[No Abstract] [Full Text] [Related]
39. Effect of mecillinam on Escherichia coli growth curves when given alone and associated with ampicillin.
Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
Scand J Infect Dis; 1986; 18(5):439-45. PubMed ID: 3535050
[TBL] [Abstract][Full Text] [Related]
40. In vitro combination of mecillinam with cephradine or amoxycillin for organisms resistant to single agents.
Chattopadhyay B; Hall I
J Antimicrob Chemother; 1979 Sep; 5(5):549-53. PubMed ID: 227829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
